McGregorS.J., TopleyN., JörresA., SpeekenbrinkA.B., GordonA., GahlG.M.Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.Kidney Int1996; 49: 525–33.
2.
KrishnanM., ThodisE., IkonomopoulosD., VidgenE., ChuM., BargmanJ.M.Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Perit Dial Int2002; 22: 573–81.
TroidleL., Gorban-BrennanN., KligerA.S., FinkelsteinF.O.Effect of duration of chronic peritoneal dialysis therapy on the development of peritonitis.Perit Dial Int1999; 19: 376–9.
5.
KofteridisD.P., ValachisA., PerakisK., MarakiS., DaphnisE., SamonisG.Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome.Int J Infect Dis2010; 14: e489–93.
6.
ZalunardoN.Y., RoseC.L., MaI.W., AltmannP.Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis.Kidney Int2007; 71: 687–92.
7.
SzetoC.C., KwanB.C., ChowK.M., LawM.C., PangW.F., ChungK.Y.Recurrent and relapsing peritonitis: causative organisms and response to treatment.Am J Kidney Dis2009; 54: 702–10.
8.
SzetoC.C., KwanB.C., ChowK.M., LawM.C., PangW.F., LeungC.B.Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases.Clin J Am Soc Nephrol2011; 6: 827–33.
